Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )

Launched by ASSIUT UNIVERSITY · Mar 28, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how nonalcoholic fatty liver disease (NAFLD) may affect the heart without obvious symptoms. The researchers want to find out if special heart imaging called speckle tracking echocardiography can help detect early heart problems in patients with NAFLD. They will also use another test called fibroscan to check the liver's condition.

To participate in this study, you need to be at least 18 years old and have some level of liver fat or scarring. However, if you have a history of heart disease, chronic liver disease, or certain other health issues, you won’t be eligible. If you join the study, you can expect to have non-invasive tests done to assess your heart and liver health. This trial is currently not recruiting participants yet, but it aims to gather important information that could help improve care for people with NAFLD in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients above age of 18 years old
• • 2. All patients showing degree of fibrosis and steatosis
• • -
• Exclusion Criteria:
• • 1-Patients diagnosed with cardiac disease (previous or current )
• • 2-patients known to have chronic liver disease
• • 3-patients younger than 18 years old
• • 4-patients with hepatocellular cancer
• • 5-patients know to be alcoholic
• • 6-patients with previous history of hypertension